Use the Back button in your browser to see the other results of your search or to select another record.
Pole striding exercise and vitamin E for management of peripheral vascular disease |
Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN |
Medicine and Science in Sports and Exercise 2003 Mar;35(3):384-393 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
PURPOSE: The purpose of this investigation was to evaluate the efficacy of pole striding exercise (a form of walking that uses muscles of the upper and lower body in a continuous movement similar to cross-country skiing) and vitamin E (alpha-tocopherol) to improve walking ability and perceived quality of life (QOL) of patients with claudication pain secondary to peripheral arterial disease (PAD). METHODS: Fifty-two subjects were randomized into four groups: pole striding with vitamin E (N = 13), pole striding with placebo (N = 14), vitamin E without exercise (N = 13), and placebo without exercise (N = 12). The dose of vitamin E was 400 IU daily. Only the pole striding with vitamin E and pole striding with placebo groups received pole striding instruction and training. Assignment to vitamin E or placebo was double blind. Subjects trained three times weekly for 30 to 45 min (rest time excluded). Individuals in vitamin E and placebo groups came to the laboratory biweekly for ankle blood-pressure measurements. RESULTS: Results of this randomized clinical trial provide strong evidence that pole striding significantly (p < 0.001) improved exercise tolerance on the constant work-rate and incremental treadmill tests. Ratings of perceived claudication pain were significantly less after the pole striding training program (p = 0.02). In contrast, vitamin E did not have a statistically significant effect on the subjects' ratings of perceived leg pain (p = 0.35) or treadmill walking duration (p = 0.36). Perceived distance and walking speed (Walking Impairment Questionnaire) and perceived physical function (Rand Short Form-36) improved in the pole striding trained group only (p < 0.001, 0.022 and 0.003, respectively). CONCLUSION: Pole striding effectively improved the exercise tolerance and perceived QOL of patients with PAD. Little additional benefit to exercise capacity was realized from vitamin E supplementation.
|